But Sohonos has not lived up to its sales potential, despite being the only drug on the market, perhaps owing to relatively ...

More than 20,000 biotechnology leaders gathered in San Diego for the 2026 BIO International Convention under the theme, ...

New analysis from the Tufts Center for the Study of Drug Development (CSDD) and Palo Alto, CA-based Medable shows that AI ...

Palo Alto, CA-based biotech Network Bio launched today with $50 million in financing. It has also announced a collaboration ...

They will be those that integrate both into a single, measurable, coordinated system — and own the behaviour layer that ...

LEO Pharma is betting up to $435 million on a pill that could give people with an ultra-rare light sensitivity disorder a way ...

That's the broad idea behind Operation TRIALBLAZER, a campaign launched this summer by HHS and the FDA. On today's podcast, ...

A therapy room used to deliver the one-off, therapist-assisted treatment. Psychedelic drug developer Definium Therapeutics has reported positive phase 3 results with its LSD-based therapy, DT120, in ...

Novo Nordisk has joined forces with Amazon Web Services (AWS) on a project that will lead to the creation of an AI co-innovation hub in London, boosting the UK's standing as a hub for AI-powered drug ...

Sanofi is laying off 229 former Blueprint Medicines employees in Cambridge, MA and closing two legacy Blueprint facilities.

DMD affects approximately 15,000 individuals in the United States and primarily impacts boys. Over time, deterioration of the ...

Blood disorder specialist Fulcrum Therapeutics has agreed to what amounts to a reverse merger with Slate Medicines, a ...